Costs and effects of fibronectin as a triage in women with threatened preterm labour.

• Conditions: threatened premature labour; 10010273

• Registration Number: NL-OMON33719
• Lead Sponsor: Academisch Medisch Centrum

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 6 May 2024

Recruitment & Eligibility

• Status: Pending
• Sex: Not specified
• Target Recruitment: 220

Inclusion Criteria

Pregnant women between 24 and 34 weeks of gestation, with a primary complaint of uterine contractions, and at least three contractions per 30 minutes.

Exclusion Criteria

Patients with vaginal bleeding, a cerclage, ruptured amniotic membranes, cervical dilatation more than 3 cm or previous treatment for preterm contractions, recent myocard infartion or unstable angina pectoris, hypertension, reasons for quick delivery.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>The primary outcome measure will be number of days to delivery, truncated at 7<br /><br>days. Secondary outcome measures will be neonatal mortality and morbidity,<br /><br>complications of<br /><br>tocolytics as well as costs. The analysis will be according to the intention to<br /><br>treat principle.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Secondary outcome measures will be neonatal mortality and morbidity,<br /><br>complications of tocolytics as well as costs. </p><br>